Article
D. Boral Capital Downgrades Quince Therapeutics to Hold
D. Boral Capital analyst Jason Kolbert downgrades Quince Therapeutics (NASDAQ:QNCX) from Buy to Hold.
Comments
- No comments yet. Be the first to comment!